Co-Enalapril-Tchaikapharma contains a combination of enalapril and hydrochlorothiazide. Enalapril is angiotensin converting enzyme (ACE) inhibitor, which lowers blood pressure by widening blood vessels. Hydrochlorothiazide is a thiazide diuretic, which lowers blood pressure by excreting more water and salts by the kidneys.
Co-Enalapril-Tchaikapharma is indicated for the treatment of:
– essential hypertension that cannot be treated with angiotensin converting enzyme inhibitor monotherapy.
Subject to medical prescription.
Concentrations and pharmaceutical form: 20 mg/12.5 mg tablets